-
Egalet, Shionogi to develop abuse-deterrent opioids
MALVERN, Pa. — Shionogi and Egalet have entered a deal worth up to $425 million for the development of abuse-deterrent opioid painkillers, Egalet said.
The deal centers on the development and potential commercialization of experimental drugs containing the opioid painkiller hydrocodone.